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Background: Hospitalized patients are at risk for torsades de pointes (TdP), due to multiple risk factors and receipt of QT-prolonging drugs. A 
reliable method of identifying patients at high risk of QT prolongation could lead to interventions to reduce TdP risk. Our objective was to develop 
and validate a risk score to identify hospitalized patients at highest risk of QT prolongation.
Methods: In this prospective study, 900 consecutive patients admitted to a cardiac unit in a large urban academic medical center comprised 
the risk score development group (DG). The developed score was then applied to 300 additional patients in a validation group (VG). Data collected 
included demographics, medical history, current diagnoses and medications, laboratory tests, and daily QT intervals. QT prolongation was defined as 
a corrected QT (QTc) of > 500 ms and/or an increase of > 60 ms. Multivariate regression analysis was performed incorporating univariate variables 
with p < 0.10.
Results: QTc prolongation occurred in 274 (30.4%) patients in the DG and 90 (30.0%) in the VG. Independent predictors of QTc prolongation 
included: female (OR, 1.5; CI, 1.1-2.0), diagnosis of myocardial infarction [2.5 (1.6-3.9)], sepsis [2.7 (1.5-4.8)], or left ventricular dysfunction [2.7 
(1.6-5.0)], administration of a QT prolonging drug [2.8 (2.0-4.0)], ≥ 2 QT prolonging drugs [2.6 (1.9-5.6)], or loop diuretic [1.4 (1.0-2.0)], age > 
68 years [1.3 (1.0-1.8)], serum K+ < 3.5 mEq/L [2.1 (1.5-2.9)], and admitting QTc > 450 ms [2.3; CI (1.6-3.2)]. Based on odds ratios, low risk 
was defined as a score of 0-6, moderate risk 7-10 and high risk 11-21. In the VG, the incidences of QTc prolongation were 13.2% (low risk); 31.7% 
(moderate risk); 67.4% (high risk). The high risk score value of > 11 predicted QTc prolongation better than other values (highest area under the 
receiver operator characteristics curve), and had sensitivity = 0.74, specificity = 0.77, positive predictive value = 0.58 and negative predictive value 
= 0.88.
Conclusions: A risk score using easily obtainable clinical risk factors predicts patients at highest risk for QTc prolongation during hospitalization 
and may be useful in guiding monitoring and treatment decisions.
